IE
RIGL icon

Israel Englander’s Rigel Pharmaceuticals RIGL Stock Holding History

Israel Englander’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-100,000
Closed -$3.54M – 4115
2018
Q1 		$3.54M Buy
+100,000
New +$4M ﹤0.01% 2008
2016
Q4 		– Sell
-15,000
Closed -$551K – 3659
2016
Q3 		$551K Buy
+15,000
New +$430K ﹤0.01% 2555

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Israel Englander's RIGL Position: Q2 2026 in Review

Israel Englander reduced its Rigel Pharmaceuticals (RIGL) stake by 65% in Q2 2026, selling an estimated $5.27M and leaving 93,689 shares worth $3.67M. The position accounts for ﹤0.01% of the portfolio, ranked #3297.

Israel Englander first reported a position in RIGL in Q2 2013 and has held it in 51 quarters since. The position peaked at $24.5M in Q3 2018. 155 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Israel Englander held 93,689 shares of Rigel Pharmaceuticals worth $3.67M as of Q2 2026.
  • Israel Englander sold 170,721 Rigel Pharmaceuticals shares in Q2 2026, an estimated $5.27M.
  • Rigel Pharmaceuticals made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3297 holding.
  • Israel Englander first reported a position in Rigel Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
  • Israel Englander's Rigel Pharmaceuticals position peaked at $24.5M in Q3 2018.
  • 155 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.